|
|
|
|
Notice to Beneficiaries of the Veterans Health Administration:
For questions pertaining to Health Care Benefits, please visit http://www.va.gov/health.
Questions pertaining to your drug therapy or other medical questions should be referred
directly to your Health Care Providers located at the VA facilities where you receive
care.
|
|
|
|
For questions pertaining to prescription renewal, please visit MyHealtheVet
at
https://www.myhealth.va.gov/. MyHealtheVet provides
access to trusted health information, links to Federal and VA benefits and resources,
the Personal Health Journal, and now online VA prescription refill.
|
|
|
|
Mission: To improve the health status of veterans by encouraging the appropriate
use of medications in a comprehensive medical care setting.
|
|
|
What is New at the PBM...
|
|
08 Feb 12
|
Pharmacy Benefits Management-Medical Advisory Panel Ez Minutes (Nov 2011 - Jan 2012)
|
|
03 Feb 12
|
Spinosad, Drug Monograph
|
|
03 Feb 12
|
Immune Globulin, Subcutaneous Liquid, Drug Monograph
|
|
03 Feb 12
|
Immune Globulin, Subcutaneous, Criteria For Use
|
|
03 Feb 12
|
Anticoagulation, Special Considerations for Women of Reproductive Age, Clinical Recommendations
|
|
03 Feb 12
|
Clopidogrel and Pharmacogenomic Testing, Clinical Recommendations
|
|
03 Feb 12
|
Influenza (oseltamivir and zanamivir), Clinical Recommendations
|
|
03 Feb 12
|
Dronedarone, Criteria For Use
|
|
13 Jan 12
|
Rilpivirine and co-formulated rilpivirine with TDF-FTC, Drug Monograph
|
|
13 Jan 12
|
Rilpivirine, Criteria For Use
|
|
13 Jan 12
|
Rilpivirine coformulated with TDF-FTC, Criteria For Use
|
|
13 Jan 12
|
Azilsartan, Drug Monograph
|
|
13 Jan 12
|
Denosumab (Prolia), Drug Monograph
|
|
13 Jan 12
|
Abiraterone, Drug Monograph
|
|
13 Jan 12
|
Simvastatin 80 mg-PBM-MAP-VPE Detailed Guidance-(December 2011), Clinical Recommendations
|
|
13 Jan 12
|
Simvastatin 80 mg Summary Guidance for Providers (December 2011), Clinical Recommendations
|
|
13 Jan 12
|
Statin (Fluva-prava-atorva-rosuva)-(December 2011), Criteria For Use
|
|
13 Jan 12
|
Dabigatran, Criteria For Use
|
|
13 Jan 12
|
Osteoporosis Algorithms Injectable Alternatives, Clinical Recommendations
|
|
13 Jan 12
|
Denosumab (Prolia), Criteria For Use
|
|
13 Jan 12
|
Teriparatide, Criteria For Use
|
|
13 Jan 12
|
Zoledronic Acid (Reclast), Criteria For Use
|
|
09 Dec 11
|
Medication Safety In Seconds - Issue 5; Volume 1; November/December 2011
|
|
29 Nov 11
|
6% Hydroxyethyl Starch 130/0.4 (Voluven®), Drug Monograph
|
|
Michael A. Valentino, R. Ph., MHSA
|
Chief Consultant
|
Biography
|
|
Joseph J. Canzolino, R. Ph.
|
Deputy Chief Consultant - Formulary Management
|
Biography
|
|
Ken Siehr, R.Ph. MS
|
Deputy Chief Consultant - CMOP
|
Biography
|
|
Timothy J. Stroup, R. Ph.
|
Deputy Chief Consultant - PBM Strategic Planning
|
Biography
|
|
Virginia Torrise, Pharm. D.
|
Deputy Chief Consultant - PBM Professional Practice and Clinical Informatics
|
Biography
|
|
Vincent Calabrese, Pharm D.
|
Associate Chief Consultant - PBM/EPS
|
Biography
|
|
Ronald A. Nosek, Jr., R.Ph., MS, FASHP
|
Associate Chief Consultant - PBM Director Meds by Mail Program-CHAMPVA
|
Biography
|
|
|
